RAPP logo
Rapport Therapeutics, Inc. Common Stock(RAPP)
Last print unknown agoAbout this dataData status
$28.60▲1.03 (3.74%)Stale · unknown old

RAPP Total Costs & Expenses

$173.52MTTM · USD

Period ending:

RAPP FY Total Costs & ExpensesUSD
RAPP FY Total Costs & Expenses2022-12-31: $10.37M2023-12-31: $36.18M2024-12-31: $83.06M2025-12-31: $125.10M$125.10M$0.00
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RAPP total costs & expenses history

Total of all costs and expenses. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Rapport Therapeutics Inc Total Costs & Expenses — Annual fiscal periods (USD)
Period endingTotal Costs & Expenses (USD)
125,099,000
83,055,000
36,179,000
10,367,000

Compare total costs & expenses

All RAPP financial metrics · RAPP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.